| review article | Q7318358 |
| scholarly article | Q13442814 |
| P50 | author | Edna B. Foa | Q5340017 |
| Monnica T. Williams | Q38523105 | ||
| P2093 | author name string | Mark Powers | |
| Yeo-Gin Yun | |||
| P2860 | cites work | Sertraline in obsessive-compulsive disorder: a double-blind comparison with placebo | Q68519551 |
| Clomipramine in obsessive-compulsive disorder | Q68544978 | ||
| Fluvoxamine versus clomipramine for obsessive-compulsive disorder: a double-blind comparison | Q71216972 | ||
| Relapse prevention program for treatment of obsessive-compulsive disorder | Q72811280 | ||
| Placebo-controlled trial of fluoxetine and phenelzine for obsessive-compulsive disorder | Q73671574 | ||
| Cognitive versus behavior therapy in the group treatment of obsessive-compulsive disorder | Q73976821 | ||
| Treatment of obsessive-compulsive disorder: cognitive behavior therapy vs. exposure and response prevention | Q81780707 | ||
| The Tuskegee Legacy Project: willingness of minorities to participate in biomedical research | Q22241544 | ||
| Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication | Q22253031 | ||
| Lifetime Prevalence and Age-of-Onset Distributions of DSM-IV Disorders in the National Comorbidity Survey Replication | Q22253034 | ||
| Randomized, Placebo-Controlled Trial of Exposure and Ritual Prevention, Clomipramine, and Their Combination in the Treatment of Obsessive-Compulsive Disorder | Q22306279 | ||
| The epidemiology of obsessive-compulsive disorder in the National Comorbidity Survey Replication | Q24654685 | ||
| Placebo-controlled, multicenter study of sertraline treatment for obsessive-compulsive disorder | Q28373711 | ||
| Long-term treatment of obsessive-compulsive disorder after an acute response: a comparison of fluoxetine versus placebo. | Q31995676 | ||
| Early childhood OCD: preliminary findings from a family-based cognitive-behavioral approach | Q33646461 | ||
| Cognitive-Behavior Therapy, Sertraline, and Their Combination for Children and Adolescents With Obsessive-Compulsive Disorder | Q33982667 | ||
| D-cycloserine augmented exposure therapy for obsessive-compulsive disorder | Q34004789 | ||
| Multicenter double-blind comparison of sertraline and desipramine for concurrent obsessive-compulsive and major depressive disorders | Q34506654 | ||
| Efficacy of sertraline in the long-term treatment of obsessive-compulsive disorder | Q34520192 | ||
| Sertraline and fluoxetine treatment of obsessive-compulsive disorder: results of a double-blind, 6-month treatment study | Q34521893 | ||
| A 1 year double-blind placebo-controlled fixed dose study of sertraline in the treatment of obsessive-compulsive disorder. | Q34721352 | ||
| Double-blind parallel comparison of three dosages of sertraline and placebo in outpatients with obsessive-compulsive disorder | Q34721772 | ||
| Augmentation of behavior therapy with D-cycloserine for obsessive-compulsive disorder | Q34744905 | ||
| Beyond misdiagnosis, misunderstanding and mistrust: relevance of the historical perspective in the medical and mental health treatment of people of color | Q36920515 | ||
| A randomized, controlled trial of cognitive-behavioral therapy for augmenting pharmacotherapy in obsessive-compulsive disorder | Q37623353 | ||
| The National Survey of American Life: a study of racial, ethnic and cultural influences on mental disorders and mental health. | Q39268003 | ||
| Psychological treatment of obsessive-compulsive disorder: a meta-analysis. | Q40059749 | ||
| Treatment of depressive and obsessive-compulsive symptoms in OCD by imipramine and behaviour therapy | Q41095716 | ||
| A controlled trial of fluvoxamine in obsessive-compulsive disorder: implications for a serotonergic theory | Q41197878 | ||
| Efficacy of fluvoxamine in obsessive-compulsive disorder. A double-blind comparison with placebo | Q41259841 | ||
| Clomipramine in obsessive-compulsive disorder. Further evidence for a serotonergic mechanism of action | Q41348845 | ||
| A comparative study of family-based and patient-based behavioural management in obsessive-compulsive disorder | Q41772266 | ||
| Fluoxetine treatment for obsessive-compulsive disorder in children and adolescents: a placebo-controlled clinical trial | Q43661536 | ||
| Behavior therapy for obsessive-compulsive disorder guided by a computer or by a clinician compared with relaxation as a control | Q43902570 | ||
| Fluoxetine in children and adolescents with OCD: a placebo-controlled trial | Q44226241 | ||
| A double-blind, placebo-controlled trial of clonazepam in obsessive-compulsive disorder | Q44312617 | ||
| Unemployment and Emergency Room Visits Predict Poor Treatment Outcome in Primary Care Panic Disorder | Q44418339 | ||
| Behavioral treatment of obsessive-compulsive disorder in African Americans: clinical issues | Q44517734 | ||
| Obsessive-compulsive disorder among African Americans and blacks of Caribbean descent: results from the National Survey of American Life | Q44633797 | ||
| Paroxetine treatment in children and adolescents with obsessive-compulsive disorder: a randomized, multicenter, double-blind, placebo-controlled trial | Q45122502 | ||
| A double-blind desipramine substitution during long-term clomipramine treatment in children and adolescents with obsessive-compulsive disorder | Q45235082 | ||
| A comparison of behavioral group therapy and individual behavior therapy in treating obsessive-compulsive disorder | Q46339879 | ||
| Randomized controlled trial of yogic meditation techniques for patients with obsessive-compulsive disorder | Q46468848 | ||
| A randomized controlled trial of Japanese patients with obsessive-compulsive disorder--effectiveness of behavior therapy and fluvoxamine | Q46641387 | ||
| Paroxetine response and tolerability among ethnic minority patients with mood or anxiety disorders: a pooled analysis. | Q46783000 | ||
| OCD symptoms in a sample of Turkish patients: a phenomenological picture | Q47221294 | ||
| Research ethics for mental health science involving ethnic minority children and youths | Q47405483 | ||
| African Americans' views on research and the Tuskegee Syphilis Study | Q48686190 | ||
| Sertraline in children and adolescents with obsessive-compulsive disorder: a multicenter randomized controlled trial | Q48779782 | ||
| Rapid benefit of intravenous pulse loading of clomipramine in obsessive-compulsive disorder. | Q50970562 | ||
| D-cycloserine does not enhance exposure-response prevention therapy in obsessive-compulsive disorder. | Q51903371 | ||
| Bridging the gap: recruitment of African-American women into mental health research studies. | Q51948081 | ||
| Cognitive-behavioral group therapy in obsessive-compulsive disorder: a randomized clinical trial. | Q51948381 | ||
| Intravenous clomipramine for obsessive-compulsive disorder refractory to oral clomipramine: a placebo-controlled study. | Q51990499 | ||
| Cognitive-behavioral treatment of obsessive thoughts: a controlled study. | Q52001219 | ||
| Treatment of obsessive-compulsive disorder with fluvoxamine: a multicentre, double-blind, placebo-controlled trial. | Q52009100 | ||
| DSM-IV field trial: obsessive-compulsive disorder. | Q52020172 | ||
| A legacy of distrust: African Americans and medical research. | Q52922975 | ||
| Change in indices of distress among Latino and Anglo female caregivers of elderly relatives with dementia: site-specific results from the REACH national collaborative study. | Q53256216 | ||
| Behavioral versus pharmacological treatments of obsessive compulsive disorder: a meta-analysis. | Q55067486 | ||
| Fluoxetine: no association with suicidality in obsessive-compulsive disorder | Q68070975 | ||
| P433 | issue | 2 | |
| P921 | main subject | obsessive-compulsive disorder | Q178190 |
| P304 | page(s) | 171-177 | |
| P577 | publication date | 2010-03-01 | |
| P1433 | published in | Journal of Anxiety Disorders | Q15758849 |
| P1476 | title | Minority participation in randomized controlled trials for obsessive-compulsive disorder | |
| P478 | volume | 24 |
| Q89222798 | Acceptability, Feasibility, and Effectiveness of Internet-Based Cognitive-Behavioral Therapy for Obsessive-Compulsive Disorder in New York |
| Q57090492 | Anxiety and Obsessive-Compulsive Disorder |
| Q90980214 | Asian Americans are less willing than other racial groups to participate in health research |
| Q50051354 | Assessing Acute Secondary Treatment Outcomes in Early-Onset Obsessive-Compulsive Disorder |
| Q36068947 | Augmenting serotonin reuptake inhibitors in obsessive-compulsive disorder: What moderates improvement? |
| Q30419581 | Barriers to treatment among African Americans with obsessive-compulsive disorder |
| Q34076454 | Can claims-based data be used to recruit black and Hispanic subjects into clinical trials? |
| Q87015927 | Characteristics of Young Children with Obsessive-Compulsive Disorder: Baseline Features from the POTS Jr. Sample |
| Q57090493 | Cognitive Behavioral Therapies |
| Q36390953 | Cognitive behavior therapy augmentation of pharmacotherapy in pediatric obsessive-compulsive disorder: the Pediatric OCD Treatment Study II (POTS II) randomized controlled trial |
| Q30410756 | Cultural barriers to African American participation in anxiety disorders research. |
| Q39831887 | Development and Preliminary Psychometric Evaluation of the Children’s Saving Inventory |
| Q34310399 | Differences in obsessive-compulsive symptoms and obsessive beliefs: a comparison between African Americans, Asian Americans, Latino Americans, and European Americans |
| Q90980139 | Evaluation of 3 approaches for increasing patient engagement in clinical research: Feedback from a community engagement advisory board |
| Q53755910 | Exploring Willingness of Elder Chinese in Houston to Participate in Clinical Research. |
| Q33860943 | Family involvement in the psychological treatment of obsessive-compulsive disorder: a meta-analysis |
| Q38411609 | Illness perception, help-seeking attitudes, and knowledge related to obsessive-compulsive disorder across different ethnic groups: a community survey |
| Q92377690 | Inclusion of special populations in clinical research: important considerations and guidelines |
| Q34145618 | Increasing Asian American participation in clinical trials by addressing community concerns. |
| Q47127372 | Latinos with obsessive-compulsive disorder: Mental healthcare utilization and inclusion in clinical trials |
| Q30238764 | Minority Representation in Migraine Treatment Trials |
| Q33912924 | Missed diagnoses in African Americans with obsessive-compulsive disorder: the structured clinical interview for DSM-IV Axis I disorders (SCID-I) |
| Q30426625 | Myth of the pure obsessional type in obsessive--compulsive disorder |
| Q57090509 | Obsessive-Compulsive Disorder |
| Q35620326 | Overcoming barriers to recruiting ethnic minorities to mental health research: a typology of recruitment strategies. |
| Q48463432 | Prospective relationship between obsessive-compulsive and depressive symptoms during multimodal treatment in pediatric obsessive-compulsive disorder |
| Q39021144 | Race/Ethnicity and Treatment Outcome in a Randomized Controlled Trial for Trichotillomania (Hair-Pulling Disorder). |
| Q35661245 | Recruitment of a hidden population: African Americans with obsessive-compulsive disorder |
| Q34976052 | Special diabetes program for Indians: retention in cardiovascular risk reduction |
| Q35098763 | Still Struggling: characteristics of youth with OCD who are partial responders to medication treatment |
| Q38075842 | Strategies to recruit minority persons: a systematic review |
| Q36032091 | Symptom Dimensions in Two Samples of Africans Americans with Obsessive-Compulsive Disorder |
| Q37633404 | The impact of a community-based clinical trial educational intervention among underrepresented Chinese Americans |
| Q30371641 | The impact of symptom dimensions on outcome for exposure and ritual prevention therapy in obsessive-compulsive disorder. |
| Q46741131 | The public's knowledge and beliefs about obsessive compulsive disorder |
| Q94596292 | The role of ethnic identity in OC symptom dimensions among Asian Americans |
| Q30417526 | The role of ethnic identity in symptoms of anxiety and depression in African Americans |
| Q37553176 | Treating ethnic minority adults with anxiety disorders: current status and future recommendations |
| Q34999866 | Treatment engagement and response to CBT among Latinos with anxiety disorders in primary care |
| Q33734927 | Treatment of obsessive-compulsive disorder in a nationwide survey of office-based physician practice |
Search more.